122 related articles for article (PubMed ID: 32108212)
1. Protein labeling approach to improve lysosomal targeting and efficacy of antibody-drug conjugates.
Han Y; Da Y; Yu M; Cheng Y; Wang X; Xiong J; Guo G; Li Y; Jiang X; Cai X
Org Biomol Chem; 2020 May; 18(17):3229-3233. PubMed ID: 32108212
[TBL] [Abstract][Full Text] [Related]
2. Lysosomal trafficking and cysteine protease metabolism confer target-specific cytotoxicity by peptide-linked anti-CD30-auristatin conjugates.
Sutherland MS; Sanderson RJ; Gordon KA; Andreyka J; Cerveny CG; Yu C; Lewis TS; Meyer DL; Zabinski RF; Doronina SO; Senter PD; Law CL; Wahl AF
J Biol Chem; 2006 Apr; 281(15):10540-7. PubMed ID: 16484228
[TBL] [Abstract][Full Text] [Related]
3. Synchronous intracellular delivery of EGFR-targeted antibody-drug conjugates by p38-mediated non-canonical endocytosis.
Takahashi JI; Nakamura S; Onuma I; Zhou Y; Yokoyama S; Sakurai H
Sci Rep; 2022 Jul; 12(1):11561. PubMed ID: 35798841
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel lysosomal trafficking peptide using phage display biopanning coupled with endocytic selection pressure.
Umlauf BJ; Mercedes JS; Chung CY; Brown KC
Bioconjug Chem; 2014 Oct; 25(10):1829-37. PubMed ID: 25188559
[TBL] [Abstract][Full Text] [Related]
5. Receptor Crosslinking: A General Method to Trigger Internalization and Lysosomal Targeting of Therapeutic Receptor:Ligand Complexes.
Moody PR; Sayers EJ; Magnusson JP; Alexander C; Borri P; Watson P; Jones AT
Mol Ther; 2015 Dec; 23(12):1888-98. PubMed ID: 26412588
[TBL] [Abstract][Full Text] [Related]
6. Improved Lysosomal Trafficking Can Modulate the Potency of Antibody Drug Conjugates.
DeVay RM; Delaria K; Zhu G; Holz C; Foletti D; Sutton J; Bolton G; Dushin R; Bee C; Pons J; Rajpal A; Liang H; Shelton D; Liu SH; Strop P
Bioconjug Chem; 2017 Apr; 28(4):1102-1114. PubMed ID: 28151644
[TBL] [Abstract][Full Text] [Related]
7. Amphipathic peptide-based fusion peptides and immunoconjugates for the targeted ablation of prostate cancer cells.
Rege K; Patel SJ; Megeed Z; Yarmush ML
Cancer Res; 2007 Jul; 67(13):6368-75. PubMed ID: 17616696
[TBL] [Abstract][Full Text] [Related]
8. Efficient Payload Delivery by a Bispecific Antibody-Drug Conjugate Targeting HER2 and CD63.
de Goeij BE; Vink T; Ten Napel H; Breij EC; Satijn D; Wubbolts R; Miao D; Parren PW
Mol Cancer Ther; 2016 Nov; 15(11):2688-2697. PubMed ID: 27559142
[TBL] [Abstract][Full Text] [Related]
9. Optimizing Lysosomal Activation of Antibody-Drug Conjugates (ADCs) by Incorporation of Novel Cleavable Dipeptide Linkers.
Salomon PL; Reid EE; Archer KE; Harris L; Maloney EK; Wilhelm AJ; Miller ML; Chari RVJ; Keating TA; Singh R
Mol Pharm; 2019 Dec; 16(12):4817-4825. PubMed ID: 31609629
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic Modeling of Antibody-Drug Conjugate Internalization at the Cellular Level Reveals Inefficient Processing Steps.
Durbin KR; Phipps C; Liao X
Mol Cancer Ther; 2018 Jun; 17(6):1341-1351. PubMed ID: 29592884
[TBL] [Abstract][Full Text] [Related]
11. Antibody-Assisted Delivery of a Peptide-Drug Conjugate for Targeted Cancer Therapy.
Kim H; Hwang D; Choi M; Lee S; Kang S; Lee Y; Kim S; Chung J; Jon S
Mol Pharm; 2019 Jan; 16(1):165-172. PubMed ID: 30521347
[TBL] [Abstract][Full Text] [Related]
12. An EGFR-targeting antibody-drug conjugate LR004-VC-MMAE: potential in esophageal squamous cell carcinoma and other malignancies.
Hu XY; Wang R; Jin J; Liu XJ; Cui AL; Sun LQ; Li YP; Li Y; Wang YC; Zhen YS; Miao QF; Li ZR
Mol Oncol; 2019 Feb; 13(2):246-263. PubMed ID: 30372581
[TBL] [Abstract][Full Text] [Related]
13. Elimination of melanoma by sortase A-generated TCR-like antibody-drug conjugates (TL-ADCs) targeting intracellular melanoma antigen MART-1.
Lai J; Wang Y; Wu SS; Ding D; Sun ZY; Zhang Y; Zhou J; Zhou Z; Xu YC; Pan LQ; Chen SQ
Biomaterials; 2018 Sep; 178():158-169. PubMed ID: 29933102
[TBL] [Abstract][Full Text] [Related]
14. Targeting HER2+ breast cancer cells: lysosomal accumulation of anti-HER2 antibodies is influenced by antibody binding site and conjugation to polymeric nanoparticles.
Owen SC; Patel N; Logie J; Pan G; Persson H; Moffat J; Sidhu SS; Shoichet MS
J Control Release; 2013 Dec; 172(2):395-404. PubMed ID: 23880472
[TBL] [Abstract][Full Text] [Related]
15. A New Triglycyl Peptide Linker for Antibody-Drug Conjugates (ADCs) with Improved Targeted Killing of Cancer Cells.
Singh R; Setiady YY; Ponte J; Kovtun YV; Lai KC; Hong EE; Fishkin N; Dong L; Jones GE; Coccia JA; Lanieri L; Veale K; Costoplus JA; Skaletskaya A; Gabriel R; Salomon P; Wu R; Qiu Q; Erickson HK; Lambert JM; Chari RV; Widdison WC
Mol Cancer Ther; 2016 Jun; 15(6):1311-20. PubMed ID: 27197308
[TBL] [Abstract][Full Text] [Related]
16. Reactivation of Mutant-EGFR Degradation through Clathrin Inhibition Overcomes Resistance to EGFR Tyrosine Kinase Inhibitors.
Ménard L; Floc'h N; Martin MJ; Cross DAE
Cancer Res; 2018 Jun; 78(12):3267-3279. PubMed ID: 29555874
[TBL] [Abstract][Full Text] [Related]
17. Targeting of EGFR by a combination of antibodies mediates unconventional EGFR trafficking and degradation.
Jones S; King PJ; Antonescu CN; Sugiyama MG; Bhamra A; Surinova S; Angelopoulos N; Kragh M; Pedersen MW; Hartley JA; Futter CE; Hochhauser D
Sci Rep; 2020 Jan; 10(1):663. PubMed ID: 31959764
[TBL] [Abstract][Full Text] [Related]
18. Site-specific traceless coupling of potent cytotoxic drugs to recombinant antibodies for pharmacodelivery.
Casi G; Huguenin-Dezot N; Zuberbühler K; Scheuermann J; Neri D
J Am Chem Soc; 2012 Apr; 134(13):5887-92. PubMed ID: 22394212
[TBL] [Abstract][Full Text] [Related]
19. Exploring the effects of linker composition on site-specifically modified antibody-drug conjugates.
Albers AE; Garofalo AW; Drake PM; Kudirka R; de Hart GW; Barfield RM; Baker J; Banas S; Rabuka D
Eur J Med Chem; 2014 Dec; 88():3-9. PubMed ID: 25176286
[TBL] [Abstract][Full Text] [Related]
20. Lysosomal targeting of the CLN7 membrane glycoprotein and transport via the plasma membrane require a dileucine motif.
Steenhuis P; Herder S; Gelis S; Braulke T; Storch S
Traffic; 2010 Jul; 11(7):987-1000. PubMed ID: 20406422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
